Logo Background RSS

Advertisement

Notable Mergers and Acquisitions of the Day 1/30: DNA, RIO/RTP, GPRO

  • Written by admin | No Comments Comments
    Last Updated: January 31st, 2009
    • Roche intends to commence a cash tender offer for all the outstanding publicly-held equity of Genentech Inc. (NYSE: DNA) at a price of $86.50. The Roche offer replaces the $89 per share proposal, that Genentech rejected in August.

      Roche currently owns 55.8% of Genentech’s public shares.

    • Companhia Vale do Rio Doce (NYSE: RIO) entered into a purchase and sale agreement with Rio Tinto Plc (NYSE: RTP) to acquire iron ore and potash assets through an all-cash transaction.

      The price to be paid for the iron assets amounts US$50 million, while the potash deposits will be acquired for US$850million, totaling US$1.6 billion.

    • Gen-Probe Incorporated

Advertisement

Leave a Comment